• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索精神分裂症的潜在认知结构:对抗精神病药物治疗反应的影响。

Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses.

作者信息

Wang Weiyan, Peng Xingjie, Hei Gangrui, Long Yujun, Xiao Jingmei, Shao Tiannan, Li Li, Yang Ye, Wang Xiaoyi, Song Chuhan, Huang Yuyan, Cai Jingda, Huang Jing, Kang Dongyu, Wang Ying, Zhao Jingping, Tang Hui, Wu Renrong

机构信息

Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, Henan, China.

出版信息

Eur Arch Psychiatry Clin Neurosci. 2025 Apr;275(3):691-699. doi: 10.1007/s00406-024-01828-6. Epub 2024 May 27.

DOI:10.1007/s00406-024-01828-6
PMID:38801534
Abstract

BACKGROUND

Individuals diagnosed with schizophrenia present diverse degrees and types of cognitive impairment, leading to variations in responses to antipsychotic treatments. Understanding the underlying cognitive structures is crucial for assessing this heterogeneity. Utilizing latent profile analysis (LPA) enables the delineation of latent categories of cognitive function. Integrating this approach with a dimensional perspective allows for the exploration of the relationship between cognitive function and treatment response.

METHODS

This study examined 647 patients from two distinct cohorts. Utilizing LPA within the discovery cohort (n = 333) and the replication cohort (n = 314), latent subtypes were identified categorically. The stability of cognitive structures was evaluated employing Latent Transition Analysis (LTA). The relationship between cognitive function and treatment response were investigated by comparing Positive and Negative Syndrome Scale (PANSS) reduction rates across diverse cognitive subtypes. Furthermore, dimensional insights were gained through correlation analyses between cognitive tests and PANSS reduction rates.

RESULTS

In terms of categorical, individuals diagnosed with schizophrenia can be categorized into three distinct subtypes: those 'without cognitive deficit', those 'with mild-moderate cognitive 'eficit', and those 'with moderate-severe cognitive deficit'. There are significant differences in PANSS reduction rates among patients belonging to these subtypes following antipsychotic treatment (p < 0.05). Furthermore, from a dimensional perspective, processing speed at baseline is positively correlated with PANSS score reduction rates at week 8/week 10 (p < 0.01).

CONCLUSIONS

Our findings have unveiled the latent subtypes of cognitive function in schizophrenia, illuminating the association between cognitive function and responses to antipsychotic treatment from both categorical and dimensional perspectives.

摘要

背景

被诊断为精神分裂症的个体存在不同程度和类型的认知障碍,导致对抗精神病药物治疗的反应存在差异。了解潜在的认知结构对于评估这种异质性至关重要。利用潜在剖面分析(LPA)能够描绘认知功能的潜在类别。将这种方法与维度视角相结合,可以探索认知功能与治疗反应之间的关系。

方法

本研究考察了来自两个不同队列的647名患者。在发现队列(n = 333)和复制队列(n = 314)中使用LPA,对潜在亚型进行分类识别。采用潜在转换分析(LTA)评估认知结构的稳定性。通过比较不同认知亚型的阳性和阴性症状量表(PANSS)减分率,研究认知功能与治疗反应之间的关系。此外,通过认知测试与PANSS减分率之间的相关分析获得维度见解。

结果

在分类方面,被诊断为精神分裂症的个体可分为三种不同的亚型:“无认知缺陷”者、“有轻度 - 中度认知缺陷”者和“有中度 - 重度认知缺陷”者。抗精神病药物治疗后,这些亚型的患者在PANSS减分率上存在显著差异(p < 0.05)。此外,从维度角度来看,基线时的处理速度与第8周/第10周的PANSS评分减分率呈正相关(p < 0.01)。

结论

我们的研究结果揭示了精神分裂症认知功能的潜在亚型,从分类和维度两个角度阐明了认知功能与抗精神病药物治疗反应之间的关联。

相似文献

1
Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses.探索精神分裂症的潜在认知结构:对抗精神病药物治疗反应的影响。
Eur Arch Psychiatry Clin Neurosci. 2025 Apr;275(3):691-699. doi: 10.1007/s00406-024-01828-6. Epub 2024 May 27.
2
Relationship between cognitive impairments and psychopathological symptoms in female schizophrenia subsequent to 8 weeks treatment with antipsychotic drugs.抗精神病药物治疗8周后女性精神分裂症患者认知障碍与精神病理症状之间的关系
BMC Psychiatry. 2025 Mar 7;25(1):211. doi: 10.1186/s12888-025-06605-w.
3
Adjunctive Memantine Treatment of Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Study.精神分裂症的辅助美金刚治疗:一项双盲、随机、安慰剂对照研究。
J Clin Psychopharmacol. 2019 Nov/Dec;39(6):634-638. doi: 10.1097/JCP.0000000000001115.
4
Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia.苯丁胺与非典型抗精神病药物(AAPD)联合治疗可改善慢性精神分裂症的神经认知功能。
Schizophr Res. 2019 Jul;209:135-140. doi: 10.1016/j.schres.2019.05.006. Epub 2019 May 14.
5
Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis.精神分裂症认知亚型:潜在剖面分析。
Schizophr Bull. 2021 Apr 29;47(3):712-721. doi: 10.1093/schbul/sbaa157.
6
Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data.卡利拉嗪治疗急性精神分裂症患者阴性症状的疗效:汇总数据的事后分析。
Schizophr Res. 2019 Feb;204:282-288. doi: 10.1016/j.schres.2018.08.020. Epub 2018 Aug 29.
7
Effects of sulforaphane on negative symptoms and cognitive impairments in chronic schizophrenia patients: A randomized double-blind trial.萝卜硫素对慢性精神分裂症患者阴性症状和认知障碍的影响:一项随机双盲试验。
J Psychiatr Res. 2025 Apr;184:464-472. doi: 10.1016/j.jpsychires.2025.03.023. Epub 2025 Mar 13.
8
Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study.治疗反应与抗精神病药诱导的首发精神分裂症药物-naive 患者体重增加相关:一项 8 周前瞻性研究。
J Clin Psychiatry. 2021 May 11;82(3):20m13469. doi: 10.4088/JCP.20m13469.
9
Latent Profiles of Cognitive Control, Episodic Memory, and Visual Perception Across Psychiatric Disorders Reveal a Dimensional Structure.精神障碍患者认知控制、情景记忆和视觉感知的潜在特征揭示了一种维度结构。
Schizophr Bull. 2020 Jan 4;46(1):154-162. doi: 10.1093/schbul/sbz025.
10
Analysis of color vision and cognitive function in first-episode schizophrenia before and after antipsychotic treatment.抗精神病药物治疗前后首发精神分裂症患者色觉和认知功能分析。
J Psychiatr Res. 2022 Aug;152:278-288. doi: 10.1016/j.jpsychires.2022.06.012. Epub 2022 Jun 13.

本文引用的文献

1
Sulforaphane Effects on Cognition and Symptoms in First and Early Episode Schizophrenia: A Randomized Double-Blind Trial.萝卜硫素对首发及早期精神分裂症认知和症状的影响:一项随机双盲试验
Schizophr Bull Open. 2022 Mar 7;3(1):sgac024. doi: 10.1093/schizbullopen/sgac024. eCollection 2022 Jan.
2
Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial.优化和个体化首发精神分裂症患者的药物治疗:一项多中心临床试验的研究方案
Front Psychiatry. 2021 Feb 25;12:611070. doi: 10.3389/fpsyt.2021.611070. eCollection 2021.
3
Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis.
精神分裂症认知亚型:潜在剖面分析。
Schizophr Bull. 2021 Apr 29;47(3):712-721. doi: 10.1093/schbul/sbaa157.
4
Distinct Polygenic Score Profiles in Schizophrenia Subgroups With Different Trajectories of Cognitive Development.精神分裂症亚组认知发展轨迹不同的独特多基因评分特征。
Am J Psychiatry. 2020 Apr 1;177(4):298-307. doi: 10.1176/appi.ajp.2019.19050527. Epub 2019 Dec 16.
5
Characterising the structure of cognitive heterogeneity in schizophrenia spectrum disorders. A systematic review and narrative synthesis.描述精神分裂症谱系障碍认知异质性的结构。系统评价和叙述性综合。
Neurosci Biobehav Rev. 2019 Dec;107:252-278. doi: 10.1016/j.neubiorev.2019.09.006. Epub 2019 Sep 7.
6
The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis.精神分裂症抗精神病反应的疗效和异质性:一项荟萃分析。
Mol Psychiatry. 2021 Apr;26(4):1310-1320. doi: 10.1038/s41380-019-0502-5. Epub 2019 Aug 30.
7
Latent Profiles of Cognitive Control, Episodic Memory, and Visual Perception Across Psychiatric Disorders Reveal a Dimensional Structure.精神障碍患者认知控制、情景记忆和视觉感知的潜在特征揭示了一种维度结构。
Schizophr Bull. 2020 Jan 4;46(1):154-162. doi: 10.1093/schbul/sbz025.
8
Parcellating cognitive heterogeneity in early psychosis-spectrum illnesses: A cluster analysis.对早期精神病谱系疾病认知异质性的分区:聚类分析。
Schizophr Res. 2018 Dec;202:91-98. doi: 10.1016/j.schres.2018.06.060. Epub 2018 Jul 2.
9
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016.全球精神分裂症的流行病学和负担:来自 2016 年全球疾病负担研究的结果。
Schizophr Bull. 2018 Oct 17;44(6):1195-1203. doi: 10.1093/schbul/sby058.
10
Intellectual and cognitive profiles in patients affected by schizophrenia.精神分裂症患者的智力和认知特征。
J Neuropsychol. 2019 Sep;13(3):589-602. doi: 10.1111/jnp.12161. Epub 2018 Apr 23.